Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


30.12.2018

1 AJNR Am J Neuroradiol
2 BMC Cancer
5 Br J Neurosurg
1 J Neurochem
6 J Neurooncol
3 J Neurosurg
5 Neuro Oncol
2 Neurosurgery
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. SPYRIS CD, Castellino RC, Schniederjan MJ, Kadom N, et al
    High-Grade Gliomas in Children with Neurofibromatosis Type 1: Literature Review and Illustrative Cases.
    AJNR Am J Neuroradiol. 2018 Dec 20. pii: ajnr.A5888. doi: 10.3174/ajnr.A5888.
    PubMed     Text format     Abstract available


    BMC Cancer

  2. FOLYOVICH A, Varga V, Varallyay G, Kozak L, et al
    A case report of isolated distal upper extremity weakness due to cerebral metastasis involving the hand knob area.
    BMC Cancer. 2018;18:947.
    PubMed     Text format     Abstract available

  3. TAN WL, Ng QS, Lim C, Tan EH, et al
    Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases.
    BMC Cancer. 2018;18:1288.
    PubMed     Text format     Abstract available


    Br J Neurosurg

  4. ZHANG JS, Qu L, Wang Q, Jin W, et al
    Intraoperative visualisation of functional structures facilitates safe frameless stereotactic biopsy in the motor eloquent regions of the brain.
    Br J Neurosurg. 2018;32:372-380.
    PubMed     Text format     Abstract available

  5. KOCAMAN U, Dalbasti T, Ozer MH, Yilmaz H, et al
    The modified lateral supraorbital approach.
    Br J Neurosurg. 2018;32:418-423.
    PubMed     Text format     Abstract available

  6. HENDERSON F JR, Skipper DC, Patel S
    Cervical spinal root cavernoma: case report and review.
    Br J Neurosurg. 2018;32:445-447.
    PubMed     Text format     Abstract available

  7. SHARMA M, Shastri S
    Single piece fronto-temporo-orbito-zygomatic craniotomy: a personal experience and review of surgical technique.
    Br J Neurosurg. 2018 Apr 25:1-7. doi: 10.1080/02688697.2018.1468017.
    PubMed     Text format     Abstract available

  8. ISLER C, Erturk Cetin O, Ugurlar D, Ozkara C, et al
    Dysembryoplastic neuroepithelial tumours: clinical, radiological, pathological features and outcome.
    Br J Neurosurg. 2018;32:436-441.
    PubMed     Text format     Abstract available


    J Neurochem

  9. ENGEL M, Gee YS, Cross D, Maccarone A, et al
    Novel Dual-Action Prodrug Triggers Apoptosis in Glioblastoma Cells by Releasing a Glutathione Quencher and Lysine-specific Histone Demethylase 1A Inhibitor.
    J Neurochem. 2018 Dec 28. doi: 10.1111/jnc.14655.
    PubMed     Text format     Abstract available


    J Neurooncol

  10. JIANG M, Long L, Zeng J, Meng W, et al
    Imaging characteristics of cerebral extraventricular neurocytoma with pathological correlation.
    J Neurooncol. 2018;140:289-296.
    PubMed     Text format     Abstract available

  11. HATZOGLOU V, Oh JH, Buck O, Lin X, et al
    Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma.
    J Neurooncol. 2018;140:351-358.
    PubMed     Text format     Abstract available

  12. WU J, Duan L, Zhang L, Sun Z, et al
    Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial.
    J Neurooncol. 2018;140:427-434.
    PubMed     Text format     Abstract available

  13. MASSIMINO M, Barretta F, Modena P, Giangaspero F, et al
    Pediatric intracranial ependymoma: correlating signs and symptoms at recurrence with outcome in the second prospective AIEOP protocol follow-up.
    J Neurooncol. 2018;140:457-465.
    PubMed     Text format     Abstract available

  14. THOMPSON EM, Landi D, Ashley D, Keir ST, et al
    Bevacizumab, irinotecan, temozolomide, tyrosine kinase inhibition, and MEK inhibition are effective against pleomorphic xanthoastrocytoma regardless of V600E status.
    J Neurooncol. 2018;140:261-268.
    PubMed     Text format     Abstract available

  15. POLASEK JB, Laviv Y, Nigim F, Rojas R, et al
    Granular cell tumor of the infundibulum: a systematic review of MR-radiography, pathology, and clinical findings.
    J Neurooncol. 2018;140:181-198.
    PubMed     Text format     Abstract available


    J Neurosurg

  16. BRACHMAN DG, Youssef E, Dardis CJ, Sanai N, et al
    Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas.
    J Neurosurg. 2018 Dec 21:1-10. doi: 10.3171/2018.7.JNS18656.
    PubMed     Text format     Abstract available

  17. TAKAMI H, Prummer CM, Graffeo CS, Peris-Celda M, et al
    Glioblastoma of the cerebellopontine angle and internal auditory canal mimicking a peripheral nerve sheath tumor: case report.
    J Neurosurg. 2018 Dec 21:1-5. doi: 10.3171/2018.8.JNS181702.
    PubMed     Text format     Abstract available

  18. SHEEHAN JP, Grills I, Chiang VL, Dong H, et al
    Quality of life outcomes for brain metastasis patients treated with stereotactic radiosurgery: pre-procedural predictive factors from a prospective national registry.
    J Neurosurg. 2018 Dec 21:1-7. doi: 10.3171/2018.8.JNS181599.
    PubMed     Text format     Abstract available


    Neuro Oncol

  19. ZHI T, Jiang K, Xu X, Yu T, et al
    ECT2/PSMD14/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1.
    Neuro Oncol. 2018 Dec 24. pii: 5260093. doi: 10.1093.
    PubMed     Text format     Abstract available

  20. PACE A, Walbert T
    Simultaneous care in neuro-oncology.
    Neuro Oncol. 2018;20:302-303.
    PubMed     Text format    

  21. COLMAN H
    A platform for efficient early evaluation of biomarker-associated therapies in newly diagnosed IDH wild-type, MGMT unmethylated glioblastoma.
    Neuro Oncol. 2019;21:6-7.
    PubMed     Text format    

  22. COLMAN H
    A platform for efficient early evaluation of biomarker-associated therapies in newly diagnosed IDH wild-type, MGMT unmethylated glioblastoma.
    Neuro Oncol. 2019;21:6-7.
    PubMed     Text format    

  23. AL-MAYHANI T, Heywood R, Vemireddy V, Lathia JD, et al
    A Non-Hierarchical Organisation of Tumorigenic NG2 Cells in Glioblastoma promoted by EGFR.
    Neuro Oncol. 2018 Dec 22. pii: 5257356. doi: 10.1093.
    PubMed     Text format     Abstract available


    Neurosurgery

  24. TRAYLOR JI, Kuo JS
    Combined Nivolumab and Ipilimumab Is an Effective Treatment for Melanoma Brain Metastases.
    Neurosurgery. 2018 Dec 19. pii: 5253943. doi: 10.1093.
    PubMed     Text format    

  25. ENE CI, Macomber MW, Barber JK, Ferreira MJ, et al
    Patterns of Failure After Stereotactic Radiosurgery for Recurrent High-Grade Glioma: A Single Institution Experience of 10 Years.
    Neurosurgery. 2018 Dec 20. pii: 5253912. doi: 10.1093.
    PubMed     Text format     Abstract available


    PLoS One

  26. HINO T, Togao O, Hiwatashi A, Yamashita K, et al
    Clinical efficacy of simplified intravoxel incoherent motion imaging using three b-values for differentiating high- and low-grade gliomas.
    PLoS One. 2018;13:e0209796.
    PubMed     Text format     Abstract available

  27. KUNDU S, Cheng Y, Shin M, Manyam G, et al
    Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
    PLoS One. 2018;13:e0195070.
    PubMed     Text format     Abstract available

  28. GARCIA-MARTINEZ A, Sottile J, Fajardo C, Riesgo P, et al
    Is it time to consider the expression of specific-pituitary hormone genes when typifying pituitary tumours?
    PLoS One. 2018;13:e0198877.
    PubMed     Text format     Abstract available

  29. MORETTI IF, Franco DG, de Almeida Galatro TF, Oba-Shinjo SM, et al
    Plasmatic membrane toll-like receptor expressions in human astrocytomas.
    PLoS One. 2018;13:e0199211.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: